Silevertinib, Black Diamond Therapeutics' lead asset, showed strong Phase 2 results with 60% ORR and 86% CNS ORR. Read why ...
Using AI and Australia's supercomputing infrastructure, researchers mapped 94 million craters on Mars, transforming planetary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results